Back

Head to head comparison of semaglutide and colchicine for treating atrial remodeling in post-MI rats with reduced ejection fraction

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Yoram Etzion

Ben-Gurion University of the Negev, Beer Sheva (Israel)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor P. Hegner (Regensburg, DE)
Abstract
Presentation thumbnail
Doctor M. Mattingsdal (Gjettum, NO)
Abstract
Presentation thumbnail
Doctor V. Jimenez Sabado (Barcelona, ES)
Abstract
Presentation thumbnail
Mrs N. Suffee (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Semaglutide improves contractile function in isolated human atrium
thumbnail
Congress Presentation
Atrial fibrillation and efficacy of semaglutide 2.4 mg in obesity-related HFpEF: A Patient Level Pooled analysis of STEP-HFpEF and STEP-HFpEF DM trials
thumbnail
Congress Presentation
STEP-HFpEF Program Echocardiography Substudy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources